Sheri Moores

Person

Spring House, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Combination therapies with bispecific anti-EGFR/c-Met antibodies an...
- Patent number 11,879,013
- Issue date Jan 23, 2024
- Janssen Biotech, Inc.
- Sylvie Laquerre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapies and patient stratification with bispecific an...
- Patent number 11,459,391
- Issue date Oct 4, 2022
- Janssen Biotech, Inc.
- Sheri Moores
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EGFR and c-Met fibronectin type III domain binding molecules
- Patent number 10,954,284
- Issue date Mar 23, 2021
- Janssen Biotech, Inc.
- Mark Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cysteine engineered fibronectin type III domain binding molecules
- Patent number 10,662,235
- Issue date May 26, 2020
- Janssen Biotech, Inc.
- Mark Anderson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
EGFR and C-Met fibronectin type III domain binding molecules
- Patent number 9,725,497
- Issue date Aug 8, 2017
- Janssen Biotech, Inc.
- Mark Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EGFR and c-Met fibronectin type III domain binding molecules
- Patent number 9,695,228
- Issue date Jul 4, 2017
- Janssen Biotech, Inc.
- Anderson Mark
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific EGFR/c-Met antibodies
- Patent number 9,695,242
- Issue date Jul 4, 2017
- Janssen Biotech, Inc.
- Mark Chiu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific EGFR/c-Met antibodies
- Patent number 9,593,164
- Issue date Mar 14, 2017
- Janssen Biotech, Inc.
- Mark Chiu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific EGFR/c-Met antibodies
- Patent number 9,580,508
- Issue date Feb 28, 2017
- Janssen Biotech, Inc.
- Mark Chiu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMBINATION THERAPIES WITH BISPECIFIC ANTI-EGFR/C-MET ANTIBODIES AN...
- Publication number 20240199748
- Publication date Jun 20, 2024
- JANSSEN BIOTECH, INC.
- Sylvie Laquerre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Anti-EGFR/Anti-Met Antibody to Treat Liver Cancer
- Publication number 20240067736
- Publication date Feb 29, 2024
- JANSSEN BIOTECH, INC.
- Sheri Moores
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPIES AND PATIENT STRATIFICATION WITH BISPECIFIC AN...
- Publication number 20230130600
- Publication date Apr 27, 2023
- JANSSEN BIOTECH, INC.
- Sheri Moores
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Cancers Lacking EGFR- Activating Mutations
- Publication number 20220298248
- Publication date Sep 22, 2022
- JANSSEN BIOTECH, INC.
- Benjamin Henley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of Non-Small Cell Lung Cancer with EGFR Mutations
- Publication number 20220064306
- Publication date Mar 3, 2022
- JANSSEN BIOTECH, INC.
- Roland Knoblauch
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific EGFR/C-Met Antibodies
- Publication number 20210395373
- Publication date Dec 23, 2021
- JANSSEN BIOTECH, INC.
- Mark Chiu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of Patients Having c-Met Exon 14 Skipping Mutations
- Publication number 20210253717
- Publication date Aug 19, 2021
- JANSSEN BIOTECH, INC.
- Roland Knoblauch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EGFR and C-Met Fibronectin Type III Domain Binding Molecules
- Publication number 20210206825
- Publication date Jul 8, 2021
- JANSSEN BIOTECH, INC.
- Mark Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination Therapies With Bispecific Anti-EGFR/c-Met Antibodies an...
- Publication number 20210017285
- Publication date Jan 21, 2021
- JANSSEN BIOTECH, INC.
- Sylvie Laquerre
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYSTEINE ENGINEERED FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES
- Publication number 20200325210
- Publication date Oct 15, 2020
- JANSSEN BIOTECH, INC.
- Mark Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination Therapies and Patient Stratification with Bispecific An...
- Publication number 20200270351
- Publication date Aug 27, 2020
- JANSSEN BIOTECH, INC.
- Sheri Moores
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific EGFR/C-Met Antibodies
- Publication number 20200087407
- Publication date Mar 19, 2020
- JANSSEN BIOTECH, INC.
- Mark Chiu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific EGFR/C-Met Antibodies
- Publication number 20180258173
- Publication date Sep 13, 2018
- JANSSEN BIOTECH, INC.
- Mark Chiu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cysteine Engineered Fibronectin Type III Domain Binding Molecules
- Publication number 20170362301
- Publication date Dec 21, 2017
- JANSSEN BIOTECH, INC.
- Mark Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EGFR and C-Met Fibronectin Type III Domain Binding Molecules
- Publication number 20170305997
- Publication date Oct 26, 2017
- JANSSEN BIOTECH, INC.
- Mark Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific EGFR/C-Met Antibodies
- Publication number 20170275367
- Publication date Sep 28, 2017
- JANSSEN BIOTECH, INC.
- Mark Chiu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific EGFR/C-Met Antibodies
- Publication number 20170101475
- Publication date Apr 13, 2017
- JANSSEN BIOTECH, INC.
- Mark Chiu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human Autotaxin Antibodies and Methods of Use
- Publication number 20150087812
- Publication date Mar 26, 2015
- JANSSEN BIOTECH, INC.
- Ellen Chi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific EGFR/C-Met Antibodies
- Publication number 20140255408
- Publication date Sep 11, 2014
- JANSSEN BIOTECH, INC.
- Mark Chiu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EGFR AND C-MET FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES
- Publication number 20140155326
- Publication date Jun 5, 2014
- JANSSEN BIOTECH, INC.
- Anderson Mark
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EGFR AND C-MET FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES
- Publication number 20140155325
- Publication date Jun 5, 2014
- JANSSEN BIOTECH, INC.
- Anderson Mark
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific EGFR/C-Met Antibodies
- Publication number 20140141000
- Publication date May 22, 2014
- JANSSEN BIOTECH, INC.
- Mark Chiu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Sheri Moores

Person

Patents Grantslast 30 patents

Combination therapies with bispecific anti-EGFR/c-Met antibodies an...

Combination therapies and patient stratification with bispecific an...

EGFR and c-Met fibronectin type III domain binding molecules

Cysteine engineered fibronectin type III domain binding molecules

EGFR and C-Met fibronectin type III domain binding molecules

EGFR and c-Met fibronectin type III domain binding molecules

Bispecific EGFR/c-Met antibodies

Bispecific EGFR/c-Met antibodies

Bispecific EGFR/c-Met antibodies

Patents Applicationslast 30 patents

COMBINATION THERAPIES WITH BISPECIFIC ANTI-EGFR/C-MET ANTIBODIES AN...

Use of Anti-EGFR/Anti-Met Antibody to Treat Liver Cancer

COMBINATION THERAPIES AND PATIENT STRATIFICATION WITH BISPECIFIC AN...

Treatment of Cancers Lacking EGFR- Activating Mutations

Treatment of Non-Small Cell Lung Cancer with EGFR Mutations

Bispecific EGFR/C-Met Antibodies

Treatment of Patients Having c-Met Exon 14 Skipping Mutations

EGFR and C-Met Fibronectin Type III Domain Binding Molecules

Combination Therapies With Bispecific Anti-EGFR/c-Met Antibodies an...

CYSTEINE ENGINEERED FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES

Combination Therapies and Patient Stratification with Bispecific An...

Bispecific EGFR/C-Met Antibodies

Bispecific EGFR/C-Met Antibodies

Cysteine Engineered Fibronectin Type III Domain Binding Molecules

EGFR and C-Met Fibronectin Type III Domain Binding Molecules

Bispecific EGFR/C-Met Antibodies

Bispecific EGFR/C-Met Antibodies

Human Autotaxin Antibodies and Methods of Use

Bispecific EGFR/C-Met Antibodies

EGFR AND C-MET FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES

EGFR AND C-MET FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES

Bispecific EGFR/C-Met Antibodies